Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Morosini Deborah Insider Profile
4 Followers
Morosini Deborah, EVP, Chief of Clinical Affairs at Prelude Therapeutics, holds 444.00 shares in Prelude Therapeutics (Ticker: PRLD). Most recently, Morosini Deborah Bought $444 shares of Prelude Therapeutics on Sep 29, 2020 for an estimated value of 8.44K.
Morosini Deborah has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Morosini Deborah's holdings
Insider Roles
EVP, Chief of Clinical Affairs
Roles that Morosini Deborah holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Morosini Deborah
Morosini Deborah's Trading History
List of latest transactions for each holding click on a transaction to see Morosini Deborah's performance on stock
You May Also Like
Morosini Deborah insider profile FAQ
What is the percentage of profitable transactions made by Morosini Deborah?
The percentage of profitable transactions made by Morosini Deborah is ―.
What is the average return per transaction made by Morosini Deborah?
The average return per transaction made by Morosini Deborah is ―.
What stocks does Morosini Deborah hold?
Morosini Deborah holds: PRLD stocks.
What was Morosini Deborah’s latest transaction?
Morosini Deborah latest transaction was an Informative Buy of $8.44K.
What was Morosini Deborah's most profitable transaction?
Morosini Deborah’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Morosini Deborah's role in Prelude Therapeutics?
Morosini Deborah's role in Prelude Therapeutics is EVP, Chief of Clinical Affairs.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.